Body Organ Biomedical Corp operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Body Organ Biomedical Corp with three other
pharmaceutical manufacturers in Asia:
Ensol Biosciences Inc
of South Korea
sales of 537.46 million Korean Won [US$475,115.86 ]
Reber Genetics Co Ltd
(30.33 million Taiwanese Dollars [US$985,248.32 ]
Syncore Biotechnology Co Ltd
(8.14 million Taiwanese Dollars [US$264,517.12 ]
During the year ended December of 2017, sales at
Body Organ Biomedical Corp were 25.53 million Taiwanese Dollars (US$829.05 thousand).
decrease of 7.3%
versus 2016, when the company's sales were 27.52 million Taiwanese Dollars.